Pharma Pulse: Antengene–UCB $1.18 Billion License Agreement and AI-Driven Value Chain Efficiencies
In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...
Flex Ltd. (NASDAQ:FLEX) is one of the best tech stocks to buy under $100. On June 24, Flex announced that it received a 2025 Manufacturing Leadership Award in the Digital Supply Chains category. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results